Koninklijke DSM Company Top Insiders
| KDSKF Stock | USD 43.02 65.78 60.46% |
Koninklijke DSM employs about 21.8 K people. The company is managed by 23 executives with a total tenure of roughly 195 years, averaging almost 8.0 years of service per executive, having 946.09 employees per reported executive. Examination of Koninklijke DSM's management performance can provide insight into the company performance.
| Robert Routs Chairman Chairman of the Supervisory Board |
| Ewald Kist Chairman Deputy Chairman of the Supervisory Board |
Koninklijke |
Koninklijke DSM Management Team Effectiveness
The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.Koninklijke DSM Workforce Comparison
Koninklijke DSM NV is rated fourth overall in number of employees category among related companies. The total workforce of Specialty Chemicals industry is now estimated at about 169,088. Koninklijke DSM retains roughly 21,760 in number of employees claiming about 13% of equities listed under Specialty Chemicals industry.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1. Koninklijke DSM NV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Koninklijke DSM NV Price Series Summation is a cross summation of Koninklijke DSM price series and its benchmark/peer.
Koninklijke DSM Notable Stakeholders
A Koninklijke DSM stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Koninklijke DSM often face trade-offs trying to please all of them. Koninklijke DSM's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Koninklijke DSM's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert Routs | Chairman of the Supervisory Board | Profile | |
| Ewald Kist | Deputy Chairman of the Supervisory Board | Profile | |
| Feike Sijbesma | Chairman of the Managing Board and CEO | Profile | |
| Dave Huizing | Vice President Investor Relations | Profile | |
| Geraldine Matchett | CFO and Member of the Managing Board | Profile | |
| Eileen Kennedy | Member of the Supervisory Board | Profile | |
| Frits Paasschen | Independent Member of the Supervisory Board | Profile | |
| John Ramsay | Independent Member of the Supervisory Board | Profile | |
| Stefan Doboczky | Member of the Managing Board | Profile | |
| Paul Gilgen | Head Products | Profile | |
| Lieke JongTops | Communications Mang | Profile | |
| Stephan Tanda | Member of the Managing Board | Profile | |
| Luca Rosetto | VP Products | Profile | |
| Dimitri Vreeze | Member of the Managing Board | Profile | |
| Rob Atsma | Head Nederland | Profile | |
| Pauline Mohr | Member of the Supervisory Board | Profile | |
| Victoria Haynes | Member of the Supervisory Board | Profile | |
| Jan Wolters | Head Chemicals | Profile | |
| Bruno Mller | Head Products | Profile | |
| Pradeep Pant | Member of the Supervisory Board | Profile | |
| Manfred Eggersdorfer | VP Advocacy | Profile | |
| Pierre Hochuli | Member of the Supervisory Board | Profile | |
| Tom Swaan | Member of the Supervisory Board | Profile |
About Koninklijke DSM Management Performance
The success or failure of an entity such as Koninklijke DSM NV often depends on how effective the management is. Koninklijke DSM management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Koninklijke management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Koninklijke management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. KONINKLIJKE DSM operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people.
The data published in Koninklijke DSM's official financial statements usually reflect Koninklijke DSM's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Koninklijke DSM NV. For example, before you start analyzing numbers published by Koninklijke accountants, it's critical to develop an understanding of what Koninklijke DSM's liquidity, profitability, and earnings quality are in the context of the Basic Materials space in which it operates.
Please note, the presentation of Koninklijke DSM's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Koninklijke DSM's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Koninklijke DSM's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Koninklijke DSM NV. Please utilize our Beneish M Score to check the likelihood of Koninklijke DSM's management manipulating its earnings.
Koninklijke DSM Workforce Analysis
Traditionally, organizations such as Koninklijke DSM use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Koninklijke DSM within its industry.Koninklijke DSM Manpower Efficiency
Return on Koninklijke DSM Manpower
| Revenue Per Employee | 423K | |
| Revenue Per Executive | 400.2M | |
| Net Income Per Employee | 77K | |
| Net Income Per Executive | 72.9M | |
| Working Capital Per Employee | 124K | |
| Working Capital Per Executive | 117.3M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Koninklijke DSM NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Koninklijke Pink Sheet analysis
When running Koninklijke DSM's price analysis, check to measure Koninklijke DSM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke DSM is operating at the current time. Most of Koninklijke DSM's value examination focuses on studying past and present price action to predict the probability of Koninklijke DSM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke DSM's price. Additionally, you may evaluate how the addition of Koninklijke DSM to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |